• Go to navigation
  • Go to content
Pulmicort - Budesonide

You are here

  • September 7, 2008

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • About Pulmicort
  • Pulmicort Turbuhaler information film
  • How to use the Turbuhaler
  • START study
  • Prescribing information
  • News
  • Press releases
  • Links
  • Sitemap
Pulmicort® (budesonide)

Pulmicort® (budesonide)

is an inhaled corticosteroid indicated for maintenance treatment of asthma in children and adults. In some countries Pulmicort is also indicated for maintenance treatment of Chronic obstructive pulmonary disease (COPD).
  • Childhood Asthma news

    • Sep 2, 2008  : Abuse doubles children's asthma risk
    • Sep 1, 2008  : BAL reveals early asthma triggers in pediatric patients
    • Aug 21, 2008  : FLG variant increases risk for asthma exacerbations
    more news
  • Pulmicort Quick Links

    • About Pulmicort
    • Using Once-daily Pulmicort
    • Pulmicort safety and side-effects
    • Using Pulmicort to treat mild asthma
    • About Pulmicort Respules®
    • Early intervention with Pulmicort
    • Pulmicort and paediatric asthma
  • Advanced search

Not signed in



  • Register
  • Forgotten password?

PubMed

  • Access PubMed

Interactive disease tutorials

  • Asthma
  • Asthma in Childhood
  • Asthma in Pregnancy

Interactive patient sites

  • New to Asthma
  • Asthma and Pregnancy
  • Asthma and Children
  • Bubbliboo

Notice

This international site is intended for health-care professionals.
Patients & carers should visit New To Asthma.com.

Quick links

  • AZ-Air.com - for respiratory specialists
  • AstraZeneca.com
  • AstraZeneca Press Office

Page tools

  • Print
  • Bookmark this page
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008